US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 192 actively recruiting studies with Wisconsin sites out of 192 registered in total. The busiest research areas in Wisconsin are Acute Myeloid Leukemia, Breast Cancer, Heart Failure. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (26), Phase 2 (44), Phase 3 (59), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
192
Recruiting Now
192
← Back to US Map
Top Conditions in Wisconsin
Acute Myeloid Leukemia (4)Breast Cancer (4)Heart Failure (4)Multiple Myeloma (3)Chronic Lymphocytic Leukemia (3)Ovarian Cancer (3)Pancreatic Adenocarcinoma (3)Stage III Pancreatic Cancer AJCC v8 (3)Advanced Solid Tumors (2)Advanced Solid Tumor (2)Non-Small Cell Lung Cancer (NSCLC) (2)Endometrial Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 192 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 192. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT06110897 N/A
Recruiting
RESISTance Exercise for Depression Trial
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT04785989 N/A
Recruiting
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
Condition
Chronic Lymphocytic Leukemia
Enrollment
16 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT07226349 Phase 1
Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Ad...
Condition
Advanced Solid Tumor
Enrollment
105 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
View Trial →
NCT05708885 N/A
Recruiting
Striated Esophageal Motor Function Modulation in Health and Disease
Condition
Dysphagia, Esophageal
Enrollment
557 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04927143 N/A
Recruiting
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentive...
Condition
Opioid-use Disorder
Enrollment
600 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT07220876 N/A
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refract...
Condition
Open Angle Glaucoma (OAG)
Enrollment
165 pts
Location
United States, South Africa
Sponsor
Avisi Technologies Inc.
View Trial →
NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
View Trial →
NCT06906341 Phase 2
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With G...
Condition
Ovarian Cancer
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Corcept Therapeutics
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04317534 Phase 2
Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I N...
Condition
NSCLC, Stage I
Enrollment
244 pts
Location
United States
Sponsor
Greg Durm, MD
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT06906107 N/A
Recruiting
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for N...
Condition
Neck Pain Musculoskeletal
Enrollment
160 pts
Location
United States
Sponsor
Baylor University
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06324201 N/A
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use i...
Condition
Paroxysmal Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
View Trial →
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
View Trial →
NCT07073352 N/A
Recruiting
ACEs, SIRT1, and Premature Vascular Aging in Humans
Condition
Adverse Childhood Experiences
Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT07477691 Phase 4
Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
Condition
Phenylketonuria
Enrollment
12 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT02508038 Phase 1
Recruiting
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric ...
Condition
Acute Myeloid Leukemia
Enrollment
22 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
Page 1 of 8 — 192 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology